Trader’s Watch List; Hanwha Solarone (NASDAQ:HSOL), Sunedison Inc (NYSE:SUNE), ReneSola (NYSE:SOL), First Solar (NASDAQ:FSLR), Suntech Power (OTCMKTS:STPFQ)



Hanwha SolarOne Co., Ltd. (NASDAQ:HSOL), a top-10 global photovoltaic manufacturer of high-quality, cost-competitive solar modules, today announced the completion of a 9.5 MWp delivery of high quality solar modules to Belgian headquartered solar company Ikaros Solar. The modules have been installed in a 3 MWp solar park in Hampshire and a 6.5 MWp in Oxfordshire, both UK. In January 2014, Hanwha SolarOne had already completed a 11.4 MWp delivery to a solar park realized by Ikaros in Norfolk County, UK. Hanwha Solarone Co Ltd (NASDAQ:HSOL) stock performance was 0.37% in last session and finished the day at $2.68. Traded volume was 702,524.00million shares in the last session and the average volume of the stock remained 1.16million shares. The beta of the stock remained 2.83. Hanwha Solarone Co Ltd (NASDAQ:HSOL) insider ownership is 1.38%.

Sunedison Inc (NYSE:SUNE) Semiconductor is now covered by analysts at Citigroup Inc.. They set a “neutral” rating on the stock. Sunedison Inc (NYSE:SUNE) dropped -0.59 percent to $22.05 Thursday on volume of 7.34million shares. The intra-day range of the stock was $21.78 to $22.41. Sunedison Inc (NYSE:SUNE) has a market capitalization of $5.90billion.

ReneSola Ltd. (ADR) (NYSE:SOL) on May 31 announced the presentation of results from a first-in-human Phase 1 study of AV-203, AVEO’s ErbB3 (HER3) inhibitory antibody candidate. Among the results, the study established a recommended Phase 2 dose of AV-203, demonstrated good tolerability and promising early signs of activity, and reached the maximum planned dose of AV-203 monotherapy. The results were presented in a poster, entitled “First-in-human Phase 1 dose-escalation study of AV-203, a monoclonal antibody against ErbB3 in patients with metastatic or advanced solid tumors” (Abstract #11113, Poster #395, S Hall A2), at the Tumor Biology General Poster Session of the American Society of Clinical Oncology 2014 Annual Meeting, taking place May 30 – June 3, 2014, in Chicago. ReneSola Ltd. (ADR) (NYSE:SOL)’s stock on June 19, 2014 reported a increase of 2.05% to the closing price of $2.99. Its fifty two weeks range is $1.95 -$6.00. The total market capitalization recorded $304.03million. The overall volume in the last trading session was 2.53million shares. In its share capital, SOL has 101.68million outstanding shares.

First Solar Inc. (NASDAQ:FSLR) has completed the 50 MW Macho Springs solar photovoltaic (PV) plant in the U.S. state of New Mexico. On Thursday, shares of First Solar, Inc. (NASDAQ:FSLR) dropped -2.12% to close the day at $68.27. Company return on investment (ROI) is 7.30% and its monthly performance is recorded as 16.44%. First Solar, Inc. (NASDAQ:FSLR) quarterly revenue growth is -3.14%.

Suntech Power Holdings Co., Ltd. (ADR) (OTCMKTS:STPFQ) stock performance was 10.53% in last session and finished the day at $0.420. Traded volume was 338,758.00million shares in the last session. The beta of the stock remained 2.70.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone